toralizumab

As nouns the difference between thromboembolism and toralizumab

is that thromboembolism is (medicine) an embolism caused by a blood clot carried in the bloodstream from its place of origin while toralizumab is a humanized monoclonal antibody and immunosuppressive drug, withdrawn because of the risk of thromboembolisms.

As nouns the difference between drug and toralizumab

is that drug is a substance used to treat an illness, relieve a symptom, or modify a chemical process in the body for a specific purpose while toralizumab is a humanized monoclonal antibody and immunosuppressive drug, withdrawn because of the risk of thromboembolisms.

As a verb drug

is to administer intoxicating drugs to, generally without the recipient's knowledge or consent.

As nouns the difference between immunosuppressive and toralizumab

is that immunosuppressive is an agent which is capable of immunosuppression while toralizumab is a humanized monoclonal antibody and immunosuppressive drug, withdrawn because of the risk of thromboembolisms.

As an adjective immunosuppressive

is having the capability to suppress the immune system, capable of immunosuppression.

As a verb humanized

is (humanize).

As a noun toralizumab is

a humanized monoclonal antibody and immunosuppressive drug, withdrawn because of the risk of thromboembolisms.